Postoperative radiotherapy in rectal cancer: Longterm results of 290 patients

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1099-1105

  Yalman, Deniz ^a   Demirci, Senem ^a   Bolukbasi, Yasemin ^a   Caliskan, Cemil ^a   Ozkok, Serdar ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Postoperative radiochemotherapy; Postoperative radiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ANUS; ARTICLE; BLADDER DISEASE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; LARGE INTESTINE DISEASE; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PANCREAS CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RETROSPECTIVE STUDY; SECOND CANCER; SKIN CANCER; SMALL INTESTINE DISEASE; STOMACH CANCER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79251565528     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kapiteijn E, Marijnen CA, Colenbrander AC, et al: Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol 1998; 24:528-535.
2. Pahlman L, Glimelius B: Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand 1984; 150:331-335. (Pubitemid 14110140)
3. McCall J, Cox MR, Wattchow DA: Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995; 10:126-132.
4. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT: Resectable adenocarcinoma of the rectum and rectosigmoid. I. Patterns of failure and survival. Cancer 1988; 61:1408-1416.
5. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G: Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983; 52:1317-1329.
6. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312:1465-1472.
7. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP Protocol R-01. J Natl Cancer Inst 1988; 80:21-29. (Pubitemid 18076565)
8. Balslev I, Pedersen M, Teglbjaerg PS, et al: Post-operative radiotherapy in Dukes B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer 1986; 58:22-28.
9. Medical Research Council Rectal Cancer Working Party: Randomised trial of sugery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348:1610-1614.
10. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet 2001; 358:1291-1304.
11. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal cancer. N Engl J Med 1991; 324:709-715.
12. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331:502-507.
13. Tveit KM, Guldvog I, Hagen S, et al: Norwegian Adjuvant Rectal Cancer Project Group: Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5 fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997; 84:1130-1135.
14. NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264:1444-1450.
15. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-1740.
16. Greene FL, Page DL Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M: AJCC Cancer Staging Manual. Sixth Edition. New York: Springer, 2002.
17. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31:1341-1346.
18. Kaplan E, Meier P: nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
19. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 2001; 345:638-646.
20. Lingareddy V, Mohiuddin M, Marks G: The importance of patient selection for adjunctive postoperative radiation therapy for cancer of the rectum. Patient selection in adjunctive therapy. Cancer 1994; 73:1805-1810. (Pubitemid 24101954)
21. Lee JH, Lee JH, Ahn JH, et al: Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence ofchemotherapy and RT: a preliminary report. J Clin Oncol 2002; 20:1751-1758.
22. Arnaud JP, Nordlinger B, Bosset JF, Boes GH, Sahmoud T, Schlag PM, Pene F: Radical surgery and postoperative RT as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 1997; 84:352-357.
23. Wolmark N, Wieand HS, Hyams DM, et al: Randomized trial of postoperative adjuvant chemotherapy with or without RT for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92:388-396.
24. Gibbs P, Chao MW, Tjandra JJ: Optimising the outcome for patients with colorectal cancer. Dis Colon Rectum 2003; 46:389-402.
25. Das P, Skibber JM, Rodriguez-Bigas MA, et al: Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006; 29:219-224.
26. Sauer R, Roedel C, Martus P, et al: Prognostic factors after neoadjuvant RCT for rectal cancer: update of the CAO/ARO/AIO-94 phase III study. J Clin Oncol 2005; 23:246s.
27. Gunderson LL, Sargent DJ, Tepper JE, et al: Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004; 22:1785-1796.
28. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K: Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002; 9:775-784.
29. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G: The lymph node ratio as prognostic factor in node positive breast cancer. Radiother Oncol 2004; 70:225-230. (Pubitemid 38520153)
30. Herr HW: Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003; 169:943-945.
31. Berger AC, Watson JC, Ross EA, Hoffman JP: The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 2004; 70:235-240.
32. Peng J, Xu Y, Guan Z, et al: Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol 2008; 15:3118-3123.
33. Edler D, Ohrling K, Hallström M, Karlberg M, Ragnhammar P: The number of analyzed lymph nodes-a prognostic factor in colorectal cancer. Acta Oncologica 2007; 46:975-981.
34. Ooi BS, Tjandra JJ, Green MD: Morbidities of adjuvant chemotherapy and RT for resectable rectal cancer: on overview. Dis Colon Rectum 1999; 42:403-418.
35. Tepper JE, O'Connell MJ, Petroni GR, et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 1997; 15:2030-2039.